Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-11-02 | 2022-08-19 |
| Drug Identification Number | 02139561 | 02139561 |
| Brand name | OXYTOCIN INJECTION, USP | OXYTOCIN INJECTION, USP |
| Common or Proper name | OXYTOCIN INJECTION, USP | OXYTOCIN INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | OXYTOCIN | OXYTOCIN |
| Strength(s) | 10UNIT | 10UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 mL | 10 mL |
| ATC code | H01BB | H01BB |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2022-10-01 | 2022-10-01 |
| Estimated end date | 2022-11-14 | 2023-01-02 |
| Actual end date | 2022-11-01 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | As previously communicated, our 10mL vial will be placed on 100% allocation in October. Contract customers will be allocated 100% of 10 mL historical monthly demand with no coverage of 1 mL possible. As the 10 mL inventory currently in circulation expires on September 30, 2022, we will be releasing October allocations on September 27, 2022 to allow early access to better dated inventory. Any quantities purchased the week of September 27, 2022 will be reduced from October allocations. Please note, newly released inventory will expire on January 31, 2023 and we anticipate fresh inventory of 10mL to be available by November 14, 2022. | Fresenius Kabi regrets to advise that our product will be placed on allocation effective Oct. 1, 2022. Contract customers will be allocated 100% of historical monthly demand. Please note that all inventory will expire on Jan. 31, 2023. |
| Health Canada comments |